| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 33 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 33 |
| 2 | TACROLIMUS OINTMENT 0.1% | 33 |
| 3 | METHYLPREDNISOLONE | 15 |
| 4 | MYCOPHENOLATE MOFETIL | 15 |
| 5 | RITUXIMAB | 15 |
| 6 | PREDNISONE | 14 |
| 7 | DEXAMETHASONE | 13 |
| 8 | DEXAMETHASONE 1.5 MG | 13 |
| 9 | REMDESIVIR | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REMDESIVIR | 12 | 0.0009 |
| 1 | BARICITINIB | 1 | 0.0003 |
| 2 | TACROLIMUS OINTMENT 0.1% | 33 | 0.0003 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 33 | 0.0003 |
| 4 | FOSCARNET SODIUM | 1 | 0.0002 |
| 5 | TACROLIMUS | 33 | 0.0002 |
| 6 | RITONAVIR 100 MG | 3 | 0.0002 |
| 7 | 0XYGEN | 7 | 0.0001 |
| 8 | OXYGEN | 7 | 0.0001 |
| 9 | BENDAMUSTINE HCL | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 12 | 0.0009 |
| 1 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 16 | 0.0001 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Corticosteroid [EPC] | 42 | 0.0000 |
| 7 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |